TLDR Steroid treatment greatly improved the symptoms of a boy with a rare disorder called Satoyoshi syndrome.
A 14-year-old boy with Satoyoshi syndrome, a rare multisystem disorder with fewer than 50 reported cases worldwide, exhibited alopecia, muscle spasms, and skeletal abnormalities. Despite extensive testing, no alternative diagnosis was found. The syndrome is believed to involve immune dysregulation. Unlike some cases, this patient did not respond to intravenous immunoglobulin therapy but showed a dramatic improvement with steroid treatment.
November 2019 in “Harper's Textbook of Pediatric Dermatology” The document is a detailed medical reference on skin and genetic disorders.
January 2022 in “Dermatology Review” Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.
72 citations
,
March 2023 in “Biomolecules” Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.
59 citations
,
June 2022 in “Frontiers in medicine” There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.
15 citations
,
January 2022 in “Immune Network/Immune network” New targeted immunotherapies are improving treatment for inflammatory skin diseases.
98 citations
,
March 2019 in “Frontiers in immunology” Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.